Okla. Stat. tit. 63, § 63-1-756.6

A. No abortion-inducing drug shall be provided without the

informed consent of the pregnant woman as described in this section

to whom the abortion-inducing drug is provided.

B. Informed consent to a chemical abortion shall be obtained at

least seventy-two (72) hours before the abortion-inducing drug is

provided to the pregnant woman, except if in reasonable medical

judgment, compliance with this subsection would pose a greater risk

of:

1. The death of the pregnant woman; or

2. The substantial and irreversible physical impairment of a

major bodily function not including psychological or emotional

conditions, of the pregnant woman.

C. A form created by the State Department of Health shall be

used by a qualified physician to obtain the consent required prior

to providing an abortion-inducing drug.

D. A consent form is not valid and consent is not sufficient,

unless:

1. The patient initials each entry, list, description or

declaration required to be on the consent form as detailed in

paragraphs 1 through 6 of subsection E of this section;

2. The patient signs the "consent statement" described in

paragraph 11 of subsection E of this section; and

3. The qualified physician signs the "qualified physician

declaration" described in paragraph 12 of subsection E of this

section.

E. The consent form shall include, but is not limited to, the

following:

1. The probable gestational age of the unborn child as

determined by both patient history and by ultrasound results used to

confirm gestational age;

2. A detailed description of the steps to complete the chemical

abortion;

3. A detailed list of the risks related to the specific

abortion-inducing drug or drugs to be used including, but not

limited to, hemorrhaging, failure to remove all tissue of the unborn

child which may require an additional procedure, sepsis, sterility

and possible continuation of pregnancy;

Oklahoma Statutes - Title 63. Public Health and Safety Page 446

4. Information about Rh incompatibility including that if she

has an Rh-negative blood type, she should receive an injection of Rh

immunoglobulin at the time of the abortion to prevent Rh

incompatibility in future pregnancies;

5. That the risks of complications from a chemical abortion

including incomplete abortion, increase with advancing gestational

age;

6. That it may be possible to reverse the effects of the

chemical abortion should she change her mind, but that time is of

the essence;

7. That she may see the remains of her unborn child in the

process of completing the abortion;

8. That initial studies suggest that children born after

reversing the effects of Mifeprex/mifepristone have no greater risk

of birth defects than the general population;

9. That initial studies suggest there is no increased risk of

maternal mortality after reversing the effects of

Mifeprex/mifepristone;

10. That information on and assistance with reversing the

effects of abortion-inducing drugs are available in the state-

prepared materials;

11. An "acknowledgment of risks and consent statement" which

shall be signed by the patient. The statement shall include, but is

not limited to, the following declarations, which shall be

individually initialed by the patient:

a. that the patient understands that the abortion-

inducing drug regimen or procedure is intended to end

her pregnancy and will result in the death of her

unborn child,

b. that the patient is not being forced to have an

abortion, that she has the choice not to have the

abortion and that she may withdraw her consent to the

abortion-inducing drug regimen even after she has

begun the abortion-inducing drug regimen,

c. that the patient understands that the chemical

abortion regimen or procedure to be used has specific

risks and may result in specific complications,

d. that the patient has been given the opportunity to ask

questions about her pregnancy, the development of her
t she may withdraw her consent to the

abortion-inducing drug regimen even after she has

begun the abortion-inducing drug regimen,

c. that the patient understands that the chemical

abortion regimen or procedure to be used has specific

risks and may result in specific complications,

d. that the patient has been given the opportunity to ask

questions about her pregnancy, the development of her

unborn child, alternatives to abortion, the abortion-

inducing drug or drugs to be used and the risks and

complications inherent to the abortion-inducing drug

or drugs to be used,

e. that she was specifically told that "Information on

the potential ability of qualified medical

professionals to reverse the effects of an abortion

obtained through the use of abortion-inducing drugs is

Oklahoma Statutes - Title 63. Public Health and Safety Page 447

available at www.abortionpillreversal.com, or you can

contact (877) 558-0333 for assistance in locating a

medical professional that can aide in the reversal of

an abortion.",

f. that she has been provided access to state-prepared,

printed materials on informed consent for abortion and

the state-prepared and maintained website on informed

consent for abortion,

g. if applicable, that she has been given the name and

phone number of the associated physician who has

agreed to provide medical care and treatment in the

event of complications associated with the abortion-

inducing drug regimen or procedure,

h. that the qualified physician will schedule an in-

person follow-up visit for the patient at

approximately seven (7) to fourteen (14) days after

providing the abortion-inducing drug or drugs to

confirm that the pregnancy is completely terminated

and to assess the degree of bleeding and other

complications, and

i. that the patient has received or been given sufficient

information to give her informed consent to the

abortion-inducing drug regimen or procedure, and

j. that the patient has a private right of action to sue

the qualified physician under the laws of this state

if she feels that she has been coerced or misled prior

to obtaining an abortion, and how to access state

resources regarding her legal right to obtain relief;

and

12. A "qualified physician declaration", which shall be signed

by the qualified physician, stating that the qualified physician has

explained the abortion-inducing drug or drugs to be used, has

provided all of the information required in subsection E of this

section, and has answered all of the woman's questions.